Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant Cancers
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
Children's Oncology Group
Hoffmann-La Roche